Ilze started her career in the pharmaceutical industry at the Upjohn Company in Kalamazoo, Michigan over 25 years ago. Prior to her extensive time in Regulatory Affairs, she held several positions in Quality Assurance. Her regulatory path not only spanned International, US and Global approaches, but also included Pharmacia, Genzyme, Baxter and Serono before Lundbeck. While she worked on INDs, NDAs, DMFs and in numerous therapeutic areas, over the past 17 years her work has included Advertising and Promotional work, with the last 10 focused solely in this area of regulatory compliance. She now heads up a team that provides promotional review and internal as well as external compliance training, and has been involved with the development and inclusion of social media in various programs in the company.
Ilze received her B.S. from Purdue University and her M.S. from The Ohio State University. She is RAC certified; participated in developing the original Code of ethics for Regulatory Professionals for RAPS; was an organizer for RAPS’s annual meetings; and has been a presenter on both labeling and advertising, and promotional topics at various conferences.
Jennifer Banovic, PharmD, MBA, BCPS, is an Executive Medical Communications Liaison at Takeda Pharmaceuticals in Deerfield, IL. Jennifer supports multiple products in the neuroscience and rheumatology therapeutic areas from a medical information and medical review perspective. She has more than 17 years of experience in various settings with a focus on medical communications, including 10 years in the pharmaceutical industry, as well as clinical practice, managed care and academia.
Leeann joined AstraZeneca in 2008 in a Marketing Operations role. She has been with the company nine years in a series of roles, with increasing responsibilities in Regulatory Affairs. She is currently an Associate Director of Promotional Regulatory Affairs, primarily responsible for the Women’s Cancer Franchise. Leeann received her undergraduate degree from Lafayette College with a double major in neuroscience and English, and a Master’s degree from Binghamton University in Behavioral Neuroscience. Prior to AstraZeneca, Leeann worked at Biogen Idec in Boston in a Marketing Operations role. She lives in Frederick, Maryland with her fiancé and their 3 cats. In her spare time, she volunteers with various mentoring programs that help foster career growth and STEM support for young women.
In her current role as Executive Director and Head of Strategic Services for Framework Solutions, Rebecca Burnett has more than 17 years of biopharmaceutical industry experience. She was most recently the Head of North America Marketing Operations for Mylan where she was responsible for leading her team in the support of five business units and more than 1,400 products.
Ms. Burnett began her career as a clinical research associate and held numerous roles in clinical research and medical affairs before finding her true passion in advertising and promotional review management in 2008. Since that time she has worked with and led teams across a spectrum of biopharmaceutical companies. Her teams have won industry awards for excellence in implementing technology solutions to drive process review efficiency and optimization. Her expertise is in diagnosing and providing recommendations to promotional review teams to ensure compliant and efficient review processes.
Ms. Burnett received her undergraduate and masters degree from the University of Colorado and has an MBA from George Washington.
Elke Carter is the Director of Regulatory Affairs for Pernix Therapeutics where she provides the expertise and leadership to assure the company is in full compliance with the regulatory requirements for the FDA, DEA, OPDP, and multiple state regulatory requirements. Ms. Carter also ensures Pernix’s adherence to best practices outlined in PhRMA code. From 2008-2012, Ms. Carter served in the same capacity as Director of Regulatory Affairs with Cypress Pharmaceutical, Inc., which was acquired by Pernix in 2012. Prior to her Director of Regulatory Affairs roles, Ms. Carter served as an R&D Chemist for Vistakon (a Johnson & Johnson Company) in Jacksonville, FL, where she worked on developing multiple combination drug and device products and was promoted to the role of R&D Operations Manager, where she and her team was responsible for the manufacture, testing and record keeping of these products, including clean room practices and FDA reviews.
Ms. Carter earned a bachelor’s degree in chemistry from The University of South Alabama. She currently resides in Jackson, MS.
Jessica Cirillo, MHS is a Director, Health Economics & Outcomes Research and Acute Care Lead at Mallinckrodt Pharmaceuticals. She is responsible for leading the development and execution of the value evidence generation and dissemination strategies for pain management and hemostats businesses.
Jessica has a broad range of experience supporting the pharmaceutical and medical device industries. Previously, Jessica was a Director in the Value Evidence and Outcomes division of GlaxoSmithKline, Inc. where she developed and implemented strategies to establish value propositions, market access, and health economics tools to support the business. Her work spanned regions around the world, including North and South Americas.
Jessica also previously worked in the Global Health Economics and Market Access division at Ethicon, Inc. (Johnson & Johnson family of companies) supporting hernia solutions. Jessica also worked at Janssen (Johnson & Johnson family of companies) in the areas of schizophrenia, major depression disorder, and bipolar disorders within in the US Health Economics and Outcomes Research team. Prior to joining Johnson & Johnson, Jessica has been a manager in operations for Wolters Kluwer Health. She was a healthcare advisor, specifically in building corporate compliance programs for major pharmaceutical clients, at PricewaterhouseCoopers. Jessica’s career began at Merck as a health outcomes intern, a medical writer, a publications coordinator, and a customer analyst located in Hoddesdon, England for 6 months.
With over 20 years of healthcare industry experience, she has developed expertise in data analytics, project management, as well as economic value modeling. Jessica is passionate about keeping patients’ well-being at the center of her work.
Jessica graduated with a Masters in Health Science from the Johns Hopkins Bloomberg School of Public Health, specializing in Health Finance and Management, which included a yearlong fellowship. She holds a BS from The Pennsylvania State University. More recently, she has earned a graduate certificate in Health Policy from the Jefferson School of Population Health. Jessica is a member of her alumni groups, the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) as well as the Healthcare Businesswoman’s Association (HBA). Over the course of her career, Jessica has received numerous awards and recognition.
Megan Francis-Sedlak is a Senior Manager of Medical Affairs at Horizon Pharma in Lake Forest. Prior to working for Horizon Pharma, Megan served as a senior member of the advertising and promotional review committee in Medical Affairs at Baxalta U.S. Inc. and Baxter Healthcare prior to the split. Megan has 12 years of experience as a research scientist and manager in the healthcare field. Megan earned a Bachelor of Science in biomedical engineering from Saint Louis University as well as a Ph.D. in biomedical engineering from Illinois Institute of Technology.
Dr. Toor is the Head and Senior Director of Commercial Regulatory Affairs at Eisai Inc. He provides strategic direction to the organization on ways to optimize the promotional review process and plays a key role in introducing technologies to enhance the efficiency of the review and approval process for promotional materials.
Previously, Dr. Toor was the Director of Client Services at an advertising firm, Bimark Inc., where he worked with many pharmaceutical industry clients in the development of promotional campaigns for a variety of therapeutic areas. His experience has spanned most therapeutic areas, although he has worked extensively in the areas of oncology, cardiometabolic disorders, GI, and allergy and asthma.
Jim has been in regulatory affairs for 19 years, of which 16 have been in the area of advertising and promotion, and he is presently with AbbVie. Jim earned a J.D. from Indiana University School of Law at Indianapolis, and has a B.A. in molecular cellular and development biology and chemistry from the University of Colorado.